Home / France / OSE Immunotherapeutics
OSE Immunotherapeutics
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
8 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
May 28, 2021 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 7, 2024 | Qube Research & Technologies Limited | 0.47% | October 9, 2024 |
| October 3, 2024 | Qube Research & Technologies Limited | 0.55% | October 9, 2024 |
| October 2, 2024 | Qube Research & Technologies Limited | 0.62% | October 9, 2024 |
| September 13, 2024 | Qube Research & Technologies Limited | 0.73% | October 9, 2024 |
| September 12, 2024 | Qube Research & Technologies Limited | 0.64% | October 9, 2024 |
| September 11, 2024 | Qube Research & Technologies Limited | 0.54% | October 9, 2024 |
| June 2, 2021 | Voleon Capital Management LP | 0.49% | June 4, 2021 |
| May 28, 2021 | Voleon Capital Management LP | 0.50% | June 4, 2021 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.55% of the capital sold short
- Teleperformance 10.50% of the capital sold short
- Renault 6.88% of the capital sold short
- FDJ United 6.06% of the capital sold short
- Worldline 5.37% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Alstom 5.31% of the capital sold short
- Viridien 4.97% of the capital sold short
- Abivax 4.85% of the capital sold short
- Vusiongroup 4.76% of the capital sold short
- Forvia 4.63% of the capital sold short